Nexalis Therapeutics Limited has released a press release.
Update on Unique Cannabis Vaporiser launch and Bodytel
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Earlier from Nexalis Therapeutics
- LSH in discussions to finance integrated cannabis producers
- B.Braun to launch Omnitest 5 BT with Body-Tel
- Unique cannabis vaporizer under evaluation in Israel
- Amended Appendix 4C - Cash balance at 31/3 $3.904M
- Update on development of unique cannabis vaporizer
Later from Nexalis Therapeutics
- Lifespot Strengthens Go-To-Market Cannabis Strategy
- LSH Acquires Seng Vital for Cannabis Opportunities
- First production completed for strong vape segment growth
- Commercial Sales and Distribution Agreement with CBDS Health
- Amended - Appendix 4C September 2018 Quarter
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics